Market Insights Health Pharmaceuticals Vaccines

Other Vaccines - Greece

Greece

In Greece, the revenue in the Other Vaccines market is forecasted to reach US$64.85m by 2024.
It is expected that the revenue will exhibit an annual growth rate (CAGR 2024-2029) of 9.65%, leading to a market volume of US$102.80m by 2029.
When compared globally, United States is projected to generate the highest revenue in the Other Vaccines market, amounting to US$24,730.00m in 2024.
Greece has seen a growing demand for other vaccines, driven by the government's proactive approach to public health.

Key regions: Australia, Brazil, United Kingdom, Europe, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The Other Vaccines market in Greece has been experiencing significant growth in recent years.

Customer preferences: Greek consumers have become more health-conscious in recent years, leading to an increased demand for preventative healthcare measures such as vaccines. Additionally, the COVID-19 pandemic has heightened awareness of the importance of vaccinations, leading to a surge in demand for all types of vaccines.

Trends in the market: The Other Vaccines market in Greece has seen a steady increase in demand over the past few years, with a particular emphasis on vaccines for diseases such as meningitis and HPV. This growth is expected to continue as the Greek government continues to prioritize preventative healthcare measures.

Local special circumstances: Greece has a relatively high incidence of certain diseases, such as meningitis, which has led to an increased demand for vaccines targeting these diseases. Additionally, the country has a high rate of HPV-related cancers, leading to a greater emphasis on HPV vaccination.

Underlying macroeconomic factors: Greece has experienced significant economic challenges in recent years, which has led to a greater emphasis on preventative healthcare measures. Additionally, the country's aging population has led to an increased demand for vaccines targeting diseases such as shingles and pneumonia. Overall, the Other Vaccines market in Greece is expected to continue its growth trajectory in the coming years.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.